Biogen

Results: 197



#Item
61Psoriasis / Alefacept / Biologic / IDEC / Medicine / Health / Pharmaceutical industry / Biogen Idec / Immunosuppressants / Astellas Pharma

For More Information Contact: MEDIA CONTACTS: Maribeth Landwehr Astellas US LLC Ph: [removed]removed]

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-19 01:05:58
62Chugai Pharmaceutical Co. / Hoffmann-La Roche / Micafungin / Biogen Idec / Natural product / Microorganism / Biology / Japan / Medicine / Astellas Pharma / Microbiology / National Institute of Technology and Evaluation

Collaborative Search for Microorganisms in Vietnam November 2, 2005 National Institute of Technology and Evaluation Astellas Pharma Inc. Chugai Pharmaceutical Co., Ltd.

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 21:59:20
63Autoimmune diseases / Anatomy / Balo concentric sclerosis / Biogen Idec / Lidwina / Sclerosis / Myelin / Corinne Goldsmith Dickinson Center for Multiple Sclerosis / Therapies under investigation for multiple sclerosis / Multiple sclerosis / Immunology / Immune system

Disclosures  Biogen Idec  Novartis  Acorda

Add to Reading List

Source URL: www.nmhr.org

Language: English - Date: 2013-08-03 13:07:36
64World Wide Web / Medicine / Multiple Sclerosis Trust / PatientsLikeMe / Multiple sclerosis / Health / Biogen Idec

2014 Joint ACTRIMS-ECTRIMS Meeting EMSP Highlights Report For us at the European Multiple Sclerosis Platform (EMSP), medical congresses are one of the highlights of our calendar and this year’s joint ACTRIMS-ECTRIMS co

Add to Reading List

Source URL: www.emsp.org

Language: English - Date: 2014-10-06 05:12:32
65World Wide Web / Medicine / Multiple Sclerosis Trust / PatientsLikeMe / Multiple sclerosis / Health / Biogen Idec

2014 Joint ACTRIMS-ECTRIMS Meeting EMSP Highlights Report For us at the European Multiple Sclerosis Platform (EMSP), medical congresses are one of the highlights of our calendar and this year’s joint ACTRIMS-ECTRIMS co

Add to Reading List

Source URL: www.emsp.org

Language: English - Date: 2014-10-06 05:10:21
66Immune system / Multiple sclerosis / Biogen Idec / Natalizumab / Interferon beta-1a / Glatiramer acetate / Fingolimod / Mitoxantrone / Therapies under investigation for multiple sclerosis / Immunology / Immunosuppressants / Medicine

July 2014 DISCLOSURES Writing and Development Team Kathleen Costello, MS, ANP – Nothing to disclose June Halper, MSN, APN-C – Consultant (CME): Biogen Idec

Add to Reading List

Source URL: www.nationalmssociety.org

Language: English - Date: 2014-09-23 13:57:08
67University of Alberta / Immunosuppressants / Academia / Education / Aaron E. Miller / James L. Vincent / Biogen Idec / Multiple sclerosis / IDEC

Leading the way in Multiple Sclerosis research November 5, 2014 A new Alberta-based research program aims to improve diagnosis and treatment for people with multiple sclerosis (Edmonton) Thousands of Albertans living wit

Add to Reading List

Source URL: eae.alberta.ca

Language: English - Date: 2014-11-05 17:17:45
68Multiple sclerosis / Medicine / Immunosuppressants / Autoimmune diseases / Antivirals / Interferon beta-1a / Glatiramer acetate / Treatment of multiple sclerosis / Interferon / Immunology / Cytokines / Immune system

PRIOR AUTHORIZATION POLICY Plegridy™ (peginterferon beta-1a injection, subcutaneous Biogen) To initiate a Coverage Review, Call[removed]

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-11-24 08:41:24
69University of Alberta / Immunosuppressants / Academia / Education / Aaron E. Miller / James L. Vincent / Biogen Idec / Multiple sclerosis / IDEC

Leading the way in Multiple Sclerosis research November 5, 2014 A new Alberta-based research program aims to improve diagnosis and treatment for people with multiple sclerosis (Edmonton) Thousands of Albertans living wit

Add to Reading List

Source URL: www.eae.alberta.ca

Language: English - Date: 2014-11-05 17:17:45
70Cytokines / Kidney diseases / Syndromes / Autoimmune diseases / Acquired hemolytic anemia / Interferon beta-1a / Biogen Idec / Thrombotic microangiopathy / Glomerulonephritis / Medicine / Health / Anatomy

Betaferon II-95 Final DHPC and Communication plan including reference to Plegridy

Add to Reading List

Source URL: www.mhra.gov.uk

Language: English - Date: 2014-10-14 07:41:24
UPDATE